The cardioprotection induced by lipopolysaccharide involves phos-phoinositide 3-kinase/Akt and high mobility group box 1 pathways

Journal of Biomedical Research - Tập 24 - Trang 324-331 - 2010
Xiang Liu1, Yijiang Chen1, Yanhu Wu1, Tuanzhu Ha2, Chuanfu Li2
1Department of Cardiothoracic Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
2Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA

Tài liệu tham khảo

Li, 1999, Early activation of transcription factor NF-κB during ischemia in perfused rat heart, Am J Physiol, 276, H543 Li, 2000, Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart, Surgery, 127, 161, 10.1067/msy.2000.101582 Li, 2001, Early activation of IKKβ during in vivo myo-cardial ischemia, Am J Physiol Heart Circ Physiol, 280, H1264, 10.1152/ajpheart.2001.280.3.H1264 Edfeldt, 2002, Expression of toll-like receptors in human atherosclerotic lesions, Circulation, 105, 1158, 10.1161/circ.105.10.1158 Baumgarten, 2001, In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4, J Infect Dis, 183, 1617, 10.1086/320712 Doan, 2009, Toll-like receptor 4 activation increas Akt phosphorylation in colon cancer cells, Anticancer Res, 29, 2473 de Kleijn, 2003, Toll-like receptors in cardiovascular diseases, Cardiovasc Res, 60, 58, 10.1016/S0008-6363(03)00348-1 Peairs, 2010, Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells, Cell Mol Immunol, 7, 123, 10.1038/cmi.2010.1 Sousa, 2010, PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-{kappa}B-independent manner, J Leukoc Biol, 87, 895, 10.1189/jlb.0809540 Kuo, 2009, Differential inhibitory effects of inotilone on inflammatory mediators, inducible nitric oxide synthase and cyclooxygenase-2, in LPS-stimulated murine macrophage, Mol Nutr Food Res, 53, 1386, 10.1002/mnfr.200800583 Li, 2009, Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccha-ride involving PI3K/Akt pathway, Int Immunopharmacol, 9, 1032, 10.1016/j.intimp.2009.04.010 Ha, 2008, Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism, Cardiovasc Res, 78, 546, 10.1093/cvr/cvn037 Fujio, 2000, Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart, Circulation, 101, 660, 10.1161/01.CIR.101.6.660 Ojaniemi, 2003, Phosphatidylinositol 3-kinase is involved in toll-like receptor 4-mediated cytokine expression in mouse macrophages, Eur J Immunol, 33, 597, 10.1002/eji.200323376 Guha, 2002, The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells, J Biol Chem, 277, 32124, 10.1074/jbc.M203298200 Fukao, 2003, PI3K and negative regulation of TLR signaling, Trends Immunol, 24, 358, 10.1016/S1471-4906(03)00139-X Williams, 1999, Inhibiting early activation of tissue nuclear factor-kB and nuclear factor interleukin 6 with (1 → 3)-β-D-glucan increases long-term survival in polymicrobial sepsis, Surgery, 126, 54, 10.1067/msy.1999.99058 Yao, 2009, Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction, J Biomed Sci, 16, 74, 10.1186/1423-0127-16-74 Wang, 2009, Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt, Cell Biol Int, 33, 665, 10.1016/j.cellbi.2009.03.006 Ulloa, 2006, High-mobility group box 1 (HMGB1) protein: friend and foe, Cytokine Growth Factor Rev, 17, 189, 10.1016/j.cytogfr.2006.01.003 Andersson, 2000, High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes, J Exp Med, 192, 565, 10.1084/jem.192.4.565 Liu, 2006, HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers, Am J Physiol, 290, C990, 10.1152/ajpcell.00308.2005 Degryse, 2001, The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells, J Cell Biol, 152, 1197, 10.1083/jcb.152.6.1197 Scaffidi, 2002, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, 418, 191, 10.1038/nature00858 Tsung, 2005, The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion, J Exp Med, 201, 1135, 10.1084/jem.20042614 Andrassy, 2008, Highmobility group box-1 in ischemia-reperfusion injury of the heart, Circulation, 117, 3216, 10.1161/CIRCULATIONAHA.108.769331 Jin, 2009, (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline(CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo, J Pharmacol Exp Ther, 330, 440, 10.1124/jpet.108.150342 Hatano, 2001, NFkappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis, Gastroenterol, 120, 1251, 10.1053/gast.2001.23239 Sha, 1995, Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses, Cell, 80, 321, 10.1016/0092-8674(95)90415-8 Tsung, 2005, The nuclear factor HMGB-1 mediates hepatic injury after murine liver ischemia-reperfusion, J Exp Med, 201, 1135, 10.1084/jem.20042614 Sappington, 2002, HMGB-1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice, Gastroenterol, 123, 790, 10.1053/gast.2002.35391 Morse, 1996, Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone, Clin Exp Immunol, 106, 389, 10.1046/j.1365-2249.1996.d01-848.x